Qualys, Inc.

Executive Summary

SELL, Medium conviction. Rated SELL, Medium conviction. Qualys just posted a strong quarter, raised FY26 guidance, and continues to beat EPS expectations, but the stock is now 52.9% above its 200-day average, 9.4% below its 52-week high, and trading well above the quantitative price target of $161.08, which implies -12.2% downside. The business quality is real, but this price asks investors to pay a premium 9.2x sales for a company still carrying only 105% NDR and guide-level revenue growth of 9% to 10%.

Investment Thesis

Qualys is not the problem. The stock is. The company just posted a genuinely good quarter, with Q2 revenue up 11% to $182.2M, current billings up 16%, and raised FY26 guidance to $732M-$738M of revenue and $7.74-$7.88 of EPS. It also continues to show unusual efficiency for security software, with FY2025 operating margin at 31.3% and Q2 FY26 adjusted EBITDA margin at 46.0%. That is a high-quality business.

The issue is what investors are paying for it after the move. At $183.48, the stock is 9.4% below its 52-week high, 10.9% below its 5-year high, and a striking 52.9% above the $119.97 200-day average after rising 112.12% in 3 months. That kind of setup leaves little room for a merely good outcome. Yet management's own guide still calls for only 9% to 10% growth, direct revenue was largely unchanged YoY, and the company explicitly is not assuming meaningful NDR improvement from the current 105% level. For a stock trading at 9.2x sales, nearly double the 4.9x peer average, those are not heroic growth markers.

The core bear case depends on three things. First, the market is extrapolating channel and ETM momentum too far before pipeline converts, even though management said much of the post-Mythos demand remains in POC and pipeline stages. Second, multiple support is weaker than it looks because the peer framework is noisy, with 7 peers and 13.4x P/E dispersion, while QLYS itself already trades close to peer P/E at 31.63x but far above peer P/S. Third, the moat is good but not expanding fast enough to justify paying a scarcity premium. QFlex is live, ETM/CSAM bookings mix improved to 12%, and sales investment rose 14%, but those are still ingredients, not proof of a sustained new growth regime.

What keeps conviction at Medium instead of High is execution quality. Management has beaten EPS estimates for 8 straight quarters, margin discipline is excellent, leverage is minimal with Debt/EBITDA 0.20, and AI could help Qualys' exposure-management workflow if conversion improves. If NDR moves clearly above 105%, direct growth reaccelerates, and FY27 starts to look like a durable low-teens grower rather than a 9% to 10% grower, the call would change. At today's price, that upside is already being pre-sold to the market.

Key Metrics

Financial Strength

Financial quality is the clear strength. Qualys runs with minimal leverage, solid liquidity, high margins, and enough cash generation to fund investment and repurchase stock without stressing the balance sheet. The important read is not just that margins are high, but that they are staying high while sales and marketing spend rose 14% in Q2 and management still expects a mid-40s % EBITDA margin for FY26. That gives the company resilience. It does not, by itself, justify paying a near-2x peer sales multiple for a business still growing around 9% to 10%.

Competitive Position

Qualys' edge is a deeply embedded cloud security and compliance platform with high profitability, sticky renewal behavior, and a broad installed base that still delivers about 90% gross retention and 105% NDR. Its operating model is unusually efficient for security software, with FY2025 operating margin at 31.3% and Q2 FY26 adjusted EBITDA margin at 46.0%, which gives it room to keep investing while staying highly profitable. Durability is decent, but not untouchable, because exposure management and remediation are increasingly strategic categories where larger security suites can bundle adjacent functionality over time.

Management & Guidance

Current guidance is better and likely credible. CFO Joo Mi Kim said, "For the full year 2026, we now expect revenues to be in the range of $732 million to $738 million, which represents a growth rate of 9% to 10%. This compares to prior guidance of $721 million to $727 million." The company also raised FY26 EPS guidance to $7.74-$7.88 and guided Q3 revenue to $185.5M-$187.5M with EPS of $1.91-$1.98. Credibility is supported by the recent beat streak, but the key caution is that management still assumes no meaningful NDR improvement and acknowledged that part of the demand uplift remains in pipeline and POC stages rather than closed revenue.

Segment Analysis

• Subscription security platform revenue (Not disclosed): Qualys reports as a largely single-platform model; Q2 FY26 revenue was $182.2M, with momentum led by ETM and patch.
• Channel-led revenue (54% of revenue): Partner mix rose from 49% a year ago, and channel remains the main growth engine while direct revenue was largely flat YoY.
• Direct revenue (Not disclosed): Growth was largely unchanged YoY in Q2 FY26, which tempers enthusiasm around the headline acceleration.
• Geography (Not disclosed): Recent geographic detail was not provided; the 2024 Q3 call flagged international growth of 14%, but that data is stale.

Capital Allocation

Capital allocation has been disciplined and shareholder-friendly. Qualys generated $0.1B of FCF, spent roughly $0.1B on buybacks, paid $0.0B in dividends, and is guiding only $8M-$12M of FY26 capex, which fits its asset-light model. The balance sheet is conservative, with Debt/Equity 0.09 and Debt/EBITDA 0.20, so management has room to repurchase shares, but buying stock aggressively after a 112.12% three-month run is less compelling than when valuation was lower.

Management Execution & Track Record

Management has earned credibility on the narrow question of guidance discipline and EPS delivery. Since the 2024 Q3 call, the company has beaten EPS estimates in 8 straight quarters, ranging from +5.1% to +19.2%, and it preserved the high-margin profile it discussed then, with Q2 FY26 adjusted EBITDA margin at 46.0% versus the 2024 Q3 framework for a mid-40s % EBITDA margin. The strategic bets management outlined in late 2024 also show partial follow-through: channel stayed strong, moving from 17% growth in the old call to 54% of revenue now, ETM/ROC matured into measurable ETM/CSAM bookings mix of 12% versus 9% a year ago, and QFlex is now live for enterprise customers. The miss is not on execution but on magnitude, because the 2024 vision around ETM, cloud, federal, and AI suggested the possibility of sharper acceleration, yet FY26 revenue guidance is still only $732M-$738M, or 9% to 10% growth, and management still assumes no meaningful NDR improvement from current levels.

Positioning & Flows

Ownership is concentrated, with the top three institutions holding 77.1%, which can support stability but also makes marginal sentiment shifts matter. Short interest is elevated at 11.06%, or 3,853,317 shares, with 4.8 days-to-cover, so the recent spike had clear squeeze fuel behind it. Options positioning is in a positive gamma regime, which can damp volatility near-term, but that signal is tactical and does not offset stretched fundamentals after the stock moved to within 9.4% of its 52-week high.

Bull Case

• Execution has been strong, with 8 straight EPS beats, including $1.98 vs $1.78 on 2026-08-04, a beat of 11.2%.
• Q2 FY26 revenue grew 11% to $182.2M, ahead of the prior growth algorithm, and current billings grew 16%, supporting the FY guide raise.
• Profitability remains elite, with FY2025 operating margin of 31.3%, net margin of 29.2%, and Q2 FY26 adjusted EBITDA margin of 46.0%, up 100 bps YoY.
• Platform adoption is improving at the margin, with NDR at 105% from 104% last quarter, ETM/CSAM mix rising to 12% of total bookings from 9% a year ago, and channel mix reaching 54% of revenue from 49%.

Bear Case

• Valuation is rich for the growth rate, with 9.2x sales versus peers at 4.9x, despite FY26 revenue guidance of only 9% to 10%.
• Management still assumes no meaningful NDR improvement from current levels in guidance, which limits upside if expansion stays near 105% rather than inflecting materially higher.
• Direct revenue was largely unchanged YoY, with growth concentrated in channels, which raises the question of how broad-based the acceleration really is.
• Much of the post-Mythos demand remains in pipeline/POC stages, not fully converted, while short interest is a notable 11.06%.

Valuation & Price Target

Engine price target $161.08 (-12.2% vs current), Low confidence.

• P/E Multiple: $192.93 (28% weight)
• PEG (growth-adjusted): $60.9 (20% weight)
• P/S Multiple: $132.17 (20% weight)
• Quality-adjusted: $206.97 (20% weight)
• DCF: $281.07 (6% weight)

The rating diverges from the quantitative baseline HOLD by leaning more heavily on setup and valuation than on raw quality. The quant engine's $161.08 target already points to -12.2% downside, and the peer set carries wide dispersion of 13.4x P/E, so a neutral stance is understandable. The reason to move to SELL is that the stock has already sprinted 112.12% in 3 months, sits 52.9% above its 200-day average, and trades at 9.2x sales versus a 4.9x peer average while the company still guides only 9% to 10% revenue growth and no material NDR lift from 105%. Sell-side consensus is also merely Hold, but that is low-signal context, not the basis for the call.

Risk Assessment

Risk score 46/100 (Moderate). The biggest risk to a bearish stance is that ETM, patch, and QFlex conversion drives revenue above $738M and pushes NDR meaningfully above 105%, forcing the market to sustain a premium multiple despite today's valuation.

The Bottom Line

QLYS rates a SELL at Medium conviction. The company is executing well, margins are excellent, and the guidance raise is real, but the stock has run much faster than the fundamentals, with 112.12% gains in 3 months against a revenue outlook still only 9% to 10%. The base case remains the engine target of $161.08, not because the business is weak, but because the price is too rich for the likely path. A move to a more positive stance would require proof that direct growth reaccelerates, NDR pushes meaningfully above 105%, and FY27 earnings power supports today's premium without depending on multiple expansion.